The Department of Health and Social Care (DHSC) has provided clarification from HMRC that VAT is not applicable on products supplied in accordance with serious shortage protocols (SSPs). From 1 June 2023, the allowance for VAT currently paid alongside product reimbursement will stop being paid when reimbursing for products supplied in accordance with SSPs. Until [...]
The post SSP VAT changes from 1 June 2023 appeared first on Community Pharmacy England.
From June 2023, the Department of Health and Social Care (DHSC) has updated its definition of Hormone Replacement Therapy to include two more products to the list of HRT medicines covered by the new HRT prepayment certificate (HRT PPC). The new additions include: Tibolone 2.5mg tablets (Livial®) Prasterone 6.5mg pessaries (Intrarosa®) The June 2023 Drug Tariff (Part XVI) [...]
The post Two new products added to the HRT PPC medicines list from June 2023 appeared first on Community Pharmacy England.
A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 16 Issue 10 May 2023) has been published and includes articles on: Direct-acting oral anticoagulants (DOACs): paediatric formulations; reminder of dose adjustments in patients with renal impairment Glucose solutions: recommendations to minimise the risks associated with the accidental use of glucose solutions [...]
The post MHRA Drug Safety Update May 2023 appeared first on PSNC Website.
Class 4 Medicines Defect Information: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) Drug alert number: EL (23)A/18 Date issued: 22 May 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Product name: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) PLGB 45985/0272 Batch No Expiry Date [...]
The post MHRA Class 4 Medicines Defect Information: Buccolam 10mg Oromucosal solution (Orifarm UK Ltd) appeared first on PSNC Website.
Update 01/09/23 – The Department of Health and Social Care (DHSC) has provided an update on the Serious Shortage Protocol (SSP) for Utrogestan® 100mg capsules (SSP056) was due to expire 1 September 2023 but has been further extended to Friday 29 September 2023. Update 09/06/23 – The Department of Health and Social Care (DHSC) has [...]
The post Extension to Utrogestan® 100mg capsules SSP (SSP056) appeared first on Community Pharmacy England.
Recent Comments